These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17060485)

  • 1. Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
    van Luijk IF; Coens C; van der Burg ME; Kobierska A; Namer M; Lhomme C; Zola P; Zanetta G; Vermorken JB;
    Ann Oncol; 2007 Feb; 18(2):275-81. PubMed ID: 17060485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study.
    Vermorken JB; Zanetta G; De Oliveira CF; van der Burg ME; Lacave AJ; Teodorovic I; Boes GH; Colombo N
    Ann Oncol; 2001 Jul; 12(7):967-74. PubMed ID: 11521804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
    Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
    Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.
    Wagenaar HC; Pecorelli S; Mangioni C; van der Burg ME; Rotmensz N; Anastasopoulou A; Zola P; Veenhof CH; Lacave AJ; Neijt JP; van Oosterom AT; Einhorn N; Vermorken JB
    Eur J Cancer; 2001 Sep; 37(13):1624-8. PubMed ID: 11527687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
    Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
    Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.
    Hasbini A; Mahjoubi R; Fandi A; Chouaki N; Taamma A; Lianes P; Cortès-Funes H; Alonso S; Armand JP; Cvitkovic E; Raymond E
    Ann Oncol; 1999 Apr; 10(4):421-5. PubMed ID: 10370784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
    Jelić S; Mitrović L; Radosavljević D; Elezar E; Babović N; Kovcin V; Tomasević Z; Kovacević S; Gavrilović D; Radulović S
    Lung Cancer; 2001 Oct; 34(1):1-13. PubMed ID: 11557107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
    Atagi S; Kawahara M; Hosoe S; Ogawara M; Kawaguchi T; Okishio K; Naka N; Sunami T; Mitsuoka S; Akira M
    Lung Cancer; 2002 Apr; 36(1):105-11. PubMed ID: 11891041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
    Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
    Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
    Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
    Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
    Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
    J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
    Gridelli C; Perrone F; Palmeri S; D'Aprile M; Cognetti F; Rossi A; Gebbia V; Pepe R; Veltri E; Airoma G; Russo A; Incoronato P; Scinto AF; Palazzolo G; Natali M; Leonardi V; Gallo C; De Placido S; Bianco AR
    Ann Oncol; 1996 Oct; 7(8):821-6. PubMed ID: 8922196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer.
    Serkies K; Jassem J; Dziadziuszko R
    Int J Gynecol Cancer; 2006; 16(3):1152-6. PubMed ID: 16803499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
    Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
    J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.
    Delaloye JF; Leyvraz S; Outcha Adjahoto E; Bauer J; De Grandi P
    Am J Clin Oncol; 1996 Apr; 19(2):204-6. PubMed ID: 8610651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer.
    Chitapanarux I; Tonusin A; Sukthomya V; Charuchinda C; Pukanhapan N; Lorvidhaya V
    Gynecol Oncol; 2003 Jun; 89(3):402-7. PubMed ID: 12798702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
    Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
    Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
    Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
    Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.